![Ian D. Fier](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ian D. Fier
Corporate Officer/Principal bij MOMENTA PHARMACEUTICALS, INC.
Profiel
Ian D.
Fier is currently the Chief Manufacturing & Program Officer at Momenta Pharmaceuticals, Inc. He previously worked as the Vice President-Clinical Affairs at BioTransplant, Inc. Fier holds an MBA degree from Boston University and an undergraduate degree from Tufts University.
Actieve functies van Ian D. Fier
Bedrijven | Functie | Begin |
---|---|---|
MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-10-2002 |
Eerdere bekende functies van Ian D. Fier
Bedrijven | Functie | Einde |
---|---|---|
BioTransplant, Inc.
![]() BioTransplant, Inc. Pharmaceuticals: MajorHealth Technology BioTransplant, Inc. is a life science company. The company discovers, develops and commercializes therapeutics, therapeutic devices and therapeutic regimens designed to suppress undesired immune responses and enhance the body's ability to accept donor cells, tissues and organs. The company was founded on March 20, 1990 and is headquartered in Charlestown, MA. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Ian D. Fier
Tufts University | Undergraduate Degree |
Boston University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Momenta Pharmaceuticals, Inc.
![]() Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
BioTransplant, Inc.
![]() BioTransplant, Inc. Pharmaceuticals: MajorHealth Technology BioTransplant, Inc. is a life science company. The company discovers, develops and commercializes therapeutics, therapeutic devices and therapeutic regimens designed to suppress undesired immune responses and enhance the body's ability to accept donor cells, tissues and organs. The company was founded on March 20, 1990 and is headquartered in Charlestown, MA. | Health Technology |